Chemotherapy for prostate cancer. Present concerns and future considerations

Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.

Clinical endocrinology·1997

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients.

The Prostate·1996

Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia.

Urological research·1996

Cytokine modulation of epidermal growth factor receptor expression on bladder cancer cells is not a major contributor to the antitumour activity of cytokines.

European journal of cancer (Oxford, England : 1990)·1995

Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy.

The Journal of urology·1995

A case for synchronous reduction of testicular androgen, adrenal androgen and prolactin for the treatment of advanced carcinoma of the prostate.

European journal of cancer (Oxford, England : 1990)·1995

Small-Cell Lung Cancer: Biology, Translational Science and Clinical Innovation.

Drugs·2026

Lunsotogene Parvec: First Approval.

Drugs·2026

Acoziborole: First Approval.

Drugs·2026

DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.

Drugs·2026

Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2- Advanced Breast Cancer.

Drugs·2026

Balancing Act: The Dual Roles of BAFF in Systemic Lupus Erythematosus.

Drugs·2026

An NLRP3 inflammasome inhibitor evoked dose-dependent anti-allodynia in the hindpaws of a rat model of chemotherapy-induced peripheral neuropathy.

Inflammopharmacology·2026

BE-BOIN: A Dose Optimization Design Accommodating Backfill and Late-Onset Toxicity.

Therapeutic innovation & regulatory science·2026

OCT4 modulates Pomc gene transcription by interfering with specific corticotroph transcription factors.

Journal of endocrinological investigation·2026

Inherently Therapeutic Plasmalogen-Based Nanoparticle Platform to Kill Ovarian Cancer Cells via Synergistic Ferroptosis Induction.

ACS biomaterials science & engineering·2026

Neurocognitive functioning of patients treated for pediatric craniopharyngioma and predictors of outcomes.

Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence·2026

GLUT-Mediated Uptake of Glyco-Trojan Horse Enables Targeted PDT for Breast Cancer.

Biomacromolecules·2026

Related Experiment Videos

Chemotherapy for prostate cancer. Present concerns and future considerations

Related Concept Videos

Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients.

Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia.

Cytokine modulation of epidermal growth factor receptor expression on bladder cancer cells is not a major contributor to the antitumour activity of cytokines.

Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy.

A case for synchronous reduction of testicular androgen, adrenal androgen and prolactin for the treatment of advanced carcinoma of the prostate.

Small-Cell Lung Cancer: Biology, Translational Science and Clinical Innovation.

Lunsotogene Parvec: First Approval.

Acoziborole: First Approval.

DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.

Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2- Advanced Breast Cancer.

Balancing Act: The Dual Roles of BAFF in Systemic Lupus Erythematosus.

An NLRP3 inflammasome inhibitor evoked dose-dependent anti-allodynia in the hindpaws of a rat model of chemotherapy-induced peripheral neuropathy.

BE-BOIN: A Dose Optimization Design Accommodating Backfill and Late-Onset Toxicity.

OCT4 modulates Pomc gene transcription by interfering with specific corticotroph transcription factors.

Inherently Therapeutic Plasmalogen-Based Nanoparticle Platform to Kill Ovarian Cancer Cells via Synergistic Ferroptosis Induction.

Neurocognitive functioning of patients treated for pediatric craniopharyngioma and predictors of outcomes.

GLUT-Mediated Uptake of Glyco-Trojan Horse Enables Targeted PDT for Breast Cancer.

Related Experiment Videos

Chemotherapy for prostate cancer. Present concerns and future considerations

Related Concept Videos

Related Articles